PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 54 filers reported holding PROQR THRAPEUTICS N V in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,483,780 | -19.8% | 1,910,600 | 0.0% | 2.85% | -30.4% |
| Q2 2023 | $3,095,172 | -23.9% | 1,910,600 | 0.0% | 4.09% | -11.1% |
| Q1 2023 | $4,069,578 | -42.4% | 1,910,600 | 0.0% | 4.60% | -31.7% |
| Q4 2022 | $7,069,220 | +848.9% | 1,910,600 | +90.7% | 6.74% | +766.1% |
| Q3 2022 | $745,000 | -4.4% | 1,001,800 | 0.0% | 0.78% | -10.9% |
| Q2 2022 | $779,000 | -14.1% | 1,001,800 | 0.0% | 0.87% | +4.7% |
| Q1 2022 | $907,000 | – | 1,001,800 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Privium Fund Management B.V. | 5,344,446 | $18,010,783 | 6.83% |
| M28 Capital Management LP | 1,910,600 | $7,069,220 | 6.74% |
| Opaleye Management Inc. | 1,460,000 | $5,402,000 | 1.88% |
| Ikarian Capital, LLC | 422,625 | $1,563,713 | 0.38% |
| Monaco Asset Management SAM | 165,000 | $610,500 | 0.18% |
| AWM Investment Company, Inc. | 166,667 | $616,668 | 0.09% |
| FRANKLIN STREET ADVISORS INC /NC | 150,000 | $555 | 0.05% |
| Atom Investors LP | 18,522 | $68,531 | 0.03% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $13,414,228 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 21,514 | $80 | 0.01% |